Emerging Health Crisis: E-cigarette Linked to Pneumonia in Vietnam

Regulations by 2FIRSTS.ai
Dec.18.2023
Emerging Health Crisis: E-cigarette Linked to Pneumonia in Vietnam
Vietnam sees a rise in young patients with pneumonia, many of whom have a history of using e-cigarettes.

Recently, according to a report by Vietnam's Law and Life newspaper, Dong Qua Province's Duoc Med Hospital has recently admitted several young patients, including middle school and high school students, who did not have chronic illnesses but were hospitalized for treatment due to pneumonia. It is noteworthy that the majority of these cases are linked to the use of e-cigarettes.

 

The Shoushou Province Hospital has reported that one of their cases involves a 16-year-old boy who sought medical attention due to chest pain, coughing up phlegm, and difficulty breathing during exertion. Inquiring about his medical history, the patient disclosed that he had recently tried using an e-cigarette with friends. He believed that e-cigarettes posed lower risks compared to traditional cigarettes and had been persuaded by his friend to give it a try.

 

After blood and phlegm tests, as well as a chest CT scan, the results revealed a widespread deep infection in the lower region of the man's right lung. Doctors have tentatively identified the origin of the pneumonia as an e-cigarette.

 

Medical expert Pei Manqiang (Bùi Mạnh Cường) stated, "The clinical course of this patient is incredibly complex. Despite being young and without any underlying conditions, the lung lesions are severe, resembling those found in elderly individuals. We have implemented treatment measures to the best of our ability in order to preserve the patient's lung function.

 

Doctors warn that e-cigarettes contain numerous harmful substances and long-term use can have an impact on health. E-cigarettes heat e-liquid, which is then converted into gas and inhaled by users, potentially leading to various health problems such as nausea, chest tightness, coughing, high blood pressure, and increased heart rate.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts to Host Special Session at InterTabac on September 19
2Firsts to Host Special Session at InterTabac on September 19
2Firsts will host a special session at the InterTabac exhibition in Dortmund on September 19, 2025, under the theme “From Change to Opportunity.” As an official media partner, 2Firsts will highlight technology, supply chain, market, and capital opportunities while fostering global dialogue.
Sep.15
JT Q3 2025: Revenue +18%, Profit +30%; RRP Volume +40%; Guidance Up
JT Q3 2025: Revenue +18%, Profit +30%; RRP Volume +40%; Guidance Up
Japan Tobacco (JT) delivered a strong Q3 2025. Revenue rose 18.3% year over year to ¥947.2 billion, with adjusted operating profit up 27.8% to ¥279.0 billion (+20.8% at constant currency) and net profit up 29.7% to ¥176.7 billion. Growth was led by reduced-risk products (RRP): total RRP volume climbed 40%, with heated tobacco (HTS) up 53%. In Japan, the launches of Ploom AURA and EVO pods pushed HTS category share to 15.5%, while the Ploom user base has nearly doubled versus two years ago.
Oct.30 by 2FIRSTS.ai
2Firsts Interview with China Tobacco International (HK): Governance and Strategic Outlook Behind ESG Rating Upgrade
2Firsts Interview with China Tobacco International (HK): Governance and Strategic Outlook Behind ESG Rating Upgrade
ESG has become a key focus for international tobacco companies. Ahead of InterTabac 2025 in Dortmund, China Tobacco International (HK) sat down with 2Firsts to outline the core initiatives behind its ESG rating upgrade, covering environmental governance, social responsibility, and corporate governance, while addressing future challenges and tightening global ESG regulations.
Sep.16
PMI Japan Unveils Limited-Edition IQOS ILUMA i “Galaxy Blue,” Priced Around $47
PMI Japan Unveils Limited-Edition IQOS ILUMA i “Galaxy Blue,” Priced Around $47
Philip Morris Japan announced it will release the limited-edition IQOS ILUMA i “Galaxy Blue” across IQOS stores nationwide starting October 29, priced at JPY 6,980 including tax (about USD 47). The new model features a space-themed design, with a members-only promotion to run at the Nagoya IQOS store.
Oct.29 by 2FIRSTS.ai
ICYMI: E-cigarette registrations in the UK drop sharply in the latest MHRA update, with 317 new codes approved from Sept 15-21. Prominent brands like IVG and LOST MARY see new device releases, while pod registrations plummet by 82%, with JUUL making a rar
ICYMI: E-cigarette registrations in the UK drop sharply in the latest MHRA update, with 317 new codes approved from Sept 15-21. Prominent brands like IVG and LOST MARY see new device releases, while pod registrations plummet by 82%, with JUUL making a rar
MHRA publicly announced over 300 e-cigarette registration codes, showing a decrease in pod submissions and new brand devices.
Sep.22 by 2FIRSTS.ai
Company | Imperial Brands CEO: Expects double-digit NGP growth over the next five years; ZONE nicotine pouches reach ~3% share in the U.S.
Company | Imperial Brands CEO: Expects double-digit NGP growth over the next five years; ZONE nicotine pouches reach ~3% share in the U.S.
At the Barclays Global Consumer Staples Conference, the CEO of Imperial Brands outlined the company’s 2025–2030 strategy and direction for its Next-Generation Products (NGP). He said the NGP business has been “reset,” delivering double-digit growth over the past two years, with the aim of sustaining this pace for the next five years. In response to disposable-vape bans in the UK and France, the company has completed a pivot to rechargeable pod systems, doubling its UK market share and surpassing
Sep.12 by 2FIRSTS.ai